TRADINTEK - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 26,904,924 | 9,429,000 | 18,241,457 | 12,586,840 | 10,062,284 | 17,271,938 | 26,209,333 | 19,367,050 |
| Profit before tax | 3,485,127 | 965,541 | 2,874,951 | 922,585 | 909,222 | 2,137,099 | 3,155,132 | 1,962,015 |
| Net profit | 2,968,028 | 824,667 | 2,444,437 | 782,609 | 772,679 | 1,817,603 | 2,663,753 | 1,673,200 |
| Equity | 6,731,805 | 6,656,472 | 8,100,909 | 7,063,518 | 6,986,197 | 8,003,800 | 9,817,553 | 10,164,753 |
| Liabilities | 3,600,734 | 2,399,587 | 2,719,152 | 1,284,444 | 3,028,440 | 8,151,884 | 3,433,320 | 5,513,877 |
| Non-current assets | 411,556 | 568,949 | 683,233 | 863,560 | 983,971 | 1,255,622 | 1,181,470 | 2,746,017 |
| Current assets | 9,851,037 | 8,420,425 | 10,254,145 | 7,350,495 | 8,974,646 | 14,664,634 | 11,945,822 | 12,729,492 |
| Total assets | 10,262,593 | 8,989,374 | 10,937,378 | 8,214,055 | 9,958,617 | 15,920,256 | 13,127,292 | 15,475,509 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,777,670 | 6,449,765 | 4,764,881 |
| Social insurance contributions | - | - | - | - | - | 427,957 | 509,790 | 630,967 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +242.7% | -65.0% | +93.5% | -31.0% | -20.1% | +71.7% | +51.7% | -26.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 28.9% | 9.2% | 22.3% | 9.5% | 7.8% | 11.4% | 20.3% | 10.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 44.1% | 12.4% | 30.2% | 11.1% | 11.1% | 22.7% | 27.1% | 16.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 11.0% | 8.7% | 13.4% | 6.2% | 7.7% | 10.5% | 10.2% | 8.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 13.0% | 10.2% | 15.8% | 7.3% | 9.0% | 12.4% | 12.0% | 10.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.4 | 0.3 | 0.2 | 0.4 | 1.0 | 0.3 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,005,792 | 323,280 | 579,094 | 381,419 | 314,446 | 513,027 | 718,064 | 523,434 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
TRADINTEK - Social security debts
The company had no debts to Sodra
TRADINTEK - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
TRADINTEK, UAB, code 124942182, is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €19.37M and net profit of €1.67M, with a profit margin of 8.6%. This followed a stronger 2024, when revenue reached €26.21M and net profit €2.66M, compared with €17.27M revenue and €1.82M net profit in 2023. On a two-year basis, revenue remained above the 2023 level, while profitability stayed positive throughout the period, though it moderated in 2025. The 2025 financial position showed total assets of €15.48M, equity of €10.16M and liabilities of €5.51M. The equity ratio stood at 65.7%, debt to equity at 0.54, and asset turnover at 1.25x. Return on equity was 16.5% and return on assets 10.8%. Revenue per employee was €523.4K and profit per employee €45.2K, indicating strong productivity for the latest year.